期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

帕金森病相关脑葡萄糖代谢网络模式及临床应用价值 被引量：6

原文传递
导出
摘要 帕金森病的早期诊断和鉴别诊断历来是神经科临床工作的难点之一，给早期治疗和新药临床试验等造成了很大的困难。近年来，随着脑代谢网络模式分析技术的成熟，18F-氟脱氧葡萄糖（FDG）正电子发射断层扫描（PET）脑显像在帕金森病诊断中的价值被重新认识，并逐渐成为帕金森病诊断和鉴别诊断的有力工具，被认为是具有里程碑意义的帕金森病脑功能显像方法之一。我们就帕金森病脑代谢网络模式的应用基础和临床应用价值等进行综述。
作者 吴平 王坚 左传涛
机构地区 复旦大学附属华山医院PET中心 学附属华山医院神经内科
出处 《中华神经科杂志》 CAS CSCD 北大核心 2012年第12期899-902,共4页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目（81171189）
关键词 帕金森病诊断 临床应用价值 网络模式 脑葡萄糖代谢 正电子发射断层扫描 新药临床试验 氟脱氧葡萄糖 鉴别诊断
分类号 R742.5 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献42

  • 1Stoessl A J, Brooks DJ, Eidelberg D. Milestones in neumimaging. Mov Disord, 2011, 26: 868-978.
  • 2Hughes A J, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson' s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55: 181-184.
  • 3Hughes AJ, Daniel SE, Lees AJ. diagnosis of Lewy body Parkinson 57 : 1497-1499.
  • 4Improved accuracy of clinical s disease. Neurology, 2001, Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 2002, 125 Pt 4: 861-870.
  • 5Morfish PK, Rakshi JS, Bailey DL, et al. Measuring the rate of progression and estimating the preclinical period of Parkinson' s disease with [ lS Fl dopa PET. J Neurol Neurosurg Psychiatry, 1998, 64: 314-319.
  • 6Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson' s disease: a metabolic network approach. Lancet Neurol, 2007, 6: 926-932.
  • 7Prakash KM, Tan EK. Development of Parkinson' s disease biomarkers. Expert Rev Neurother, 2010, l0 : 1811-1825.
  • 8Tatsch K. Positron emission tomography in diagnosis and differential diagnosis of Parkinson' s disease. Neurodegener Dis, 2010, 7: 330-340.
  • 9Au WL, Adams JR, Troiano AR, et al. Parkinson' s disease : in vivo assessment of disease progression using positron emission tomography. Brain Res Mol Brain Res, 2005, 134: 24-33.
  • 10Wang J, Zuo CT, Jiang YP, et al. ~SF-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson' s disease in various Hoehn&Yahr stages. J Neurol, 2007, 254: 185-190.

二级参考文献59

  • 1蒋雨平,王坚,丁正同,管一晖,赵军,陈正平,项景德,苏惠琳.^(18)F-FP-CIT PET和^(99)Tc^m-TRODAT-1 SPECT纹状体DAT显像在早期诊断帕金森病中的敏感性比较[J].中国临床神经科学,2006,14(2):128-133. 被引量：4
  • 2Brooks DJ,Frey KA,Marek KL,et al.Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.Exp Neural,2003,184 Suppl 1:S68-79.
  • 3Dabwan V,Ma Y,Pillai V,et al.Comparative analysis of striatal FDOPA uptake in Parkinson' s disease:ratio method versus graphical approach.J Nucl Med,2002,43:1324-1330.
  • 4Eshuis SA,Jager PL,Maguire RP,et al.Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson' s disease and healthy controls.Eur J Nucl Med Mol Imaging,2009,36:454-462.
  • 5Malter W,Liepelt I,Berg D.Progression of Parkinson' s disease in the clinical phase:potential markers.Lancet Neural,2009,8:1158-1171.
  • 6Breit S,Reimold M,Reischl G,et al.11C d-threomethylphenidate PET in patients with Parkinson' s disease and essential tremor.J Neural Transm,2006,113:187-193.
  • 7Zijlmans J,Evans A,Fonts F,et al.123I FP-CIT spect study in vascular parkinsonism and Parkinson' s disease.Mov Disord,2007,22:1278-1285.
  • 8Stoffers D,Booij J,Bosscher L,et al.Early-stage 123I beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson' s disease.Eur J Nucl Med Mol Imaging,2005,32:689-695.
  • 9Seppi K,Scherfler C,Donnemiller E,et al.Topography of dopamine transporter availability in progressive supranuclear palsy:a voxelwise 123I beta-CIT SPECT analysis.Arch Neurol,2006,63:1154-1160.
  • 10Parkinson Study Group.A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism.Neurology,2000,55:1540-1547.

共引文献4

同被引文献75

  • 1张锦明,田嘉禾,郭喆,丁为民,姚树林,尹大一,刘伯里.在线自动化制备多巴胺转运蛋白显像剂^(11)C-β-CFT[J].中华核医学杂志,2005,25(3):142-145. 被引量：25
  • 2高平,秦绍森,蔡晓杰,刘银红,韩丽君,于治国.Alzheimer病与轻度认知功能障碍的脑SPECT显像[J].中华核医学杂志,2006,26(4):213-215. 被引量：9
  • 3中华医学会神经病学分会帕金森病及运动障碍学组 中华医学会神经病学分会神经心理学与行为神经病学组.帕金森病痴呆的诊断与治疗指南[J].中华神经科杂志,2011,.
  • 4Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson' s disease cohort. Brain, 2007, 130(Pt 7) : 1787-1798.
  • 5Leroi I, Mcdonald K, Pantula H, et al. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol, 2012, 25: 208- 214.
  • 6Jokinen P, Scheinin N, Aaho S, et al. [ ( 11 ) C 1 PIB-, [ ( 18 ) F ] FDG-PET and MRI imaging in patients with Parkinson' s disease with and without dementia. Parkinsonism Relat Disord, 2010, 16 : 666-670.
  • 7Hosokai Y, Nishio Y, Hirayama K, et al. Distinct patterns of regional cerebral glucose metabolism in Parkinson' s disease with and without mild cognitive impairment. Mov Disord, 2009, 24: 854 -862.
  • 8Bohnen NI, Koeppe RA, Minoshima S, et al. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med, 2011, 52: 848-855.
  • 9Hirano S, Shinotoh H, Eidelberg D. Functional brain imaging of cognitive dysfunction in Parkinson' s disease. J Neurol Neurosurg Psychiatry, 2012, 83: 963-969.
  • 10Wu P, Wang J, Peng S, et al. Metabolic brain network in the Chinese patients with Parkinson' s disease based on (18)F-FDG PET imaging. Parkinsonism Relat Disord, 2013, 19: 622-627.

引证文献6

二级引证文献28

中华神经科杂志
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部